Patient NavigationSpermatocidal AgentsProstateNeoplasmsProstatic NeoplasmsNuclear MedicineTechnetiumProstate-Specific AntigenRadioisotopesRadiochemistryRadionuclide ImagingGallium RadioisotopesRheniumTinTechnetium CompoundsPoloniumReceptors, AndrogenAndrogensCell Line, TumorRadiation DosageAndrogen AntagonistsProstatectomyOrganotechnetium CompoundsIsotope LabelingPentetic AcidRadionuclide GeneratorsCopper RadioisotopesTissue DistributionRadiometryMercury RadioisotopesProstatic HyperplasiaIndium RadioisotopesSamariumPositron-Emission TomographyGene Expression Regulation, NeoplasticWhole-Body CountingBone NeoplasmsIodine RadioisotopesOrchiectomyMice, NudeNeoplasms, Hormone-DependentSensitivity and SpecificityRadioactivityRadiation ProtectionOrganometallic CompoundsEarly Detection of CancerTumor Markers, BiologicalThiosemicarbazonesMinicomputersAdenocarcinomaDisease ProgressionNeoplasm MetastasisSodium Pertechnetate Tc 99mIndiumRadiumAstatineProstatic Intraepithelial NeoplasiaRelative Biological EffectivenessTechnetium Tc 99m MedronateRadioactive TracersNeoplasm TransplantationTechnetium Tc 99m LidofeninTosyl CompoundsAlpha ParticlesTomography, Emission-Computed, Single-PhotonDiagnostic ImagingNeoplasm InvasivenessBody BurdenNeoplasm StagingNeoplasm GradingFluorine RadioisotopesBreast NeoplasmsPrognosisCell ProliferationTin CompoundsTomography, Emission-ComputedTumor Cells, CulturedGenetic Predisposition to DiseaseYttrium RadioisotopesAntineoplastic AgentsAntineoplastic Agents, HormonalReverse Transcriptase Polymerase Chain ReactionApoptosisSugar AcidsRisk FactorsLipoproteins, IDLReproducibility of ResultsAndrogen Receptor AntagonistsClick ChemistryYtterbiumXenograft Model Antitumor AssaysTechnology, RadiologicSodium IodideRadiotherapy DosageFluorineDigital Rectal ExaminationAnilidesFluorodeoxyglucose F18Prospective StudiesVaccines, Inactivated